AIM DEVELOPING MARKETS FUND Sample Clauses

AIM DEVELOPING MARKETS FUND. NET ASSETS ANNUAL RATE ---------- ----------- First $500 million................................................. 0.975% Next $500 million.................................................. 0.95% Next $500 million.................................................. 0.925% On amounts thereafter.............................................. 0.90% AIM ENHANCED SHORT BOND FUND NET ASSETS ANNUAL RATE ---------- ----------- First $1 billion................................................... 0.45% Next $4 billion.................................................... 0.425% Over $5 billion.................................................... 0.40% AIM INTERNATIONAL BOND FUND NET ASSETS ANNUAL RATE ---------- ----------- First $250 million................................................. 0.65% Next $250 million.................................................. 0.59% Next $500 million.................................................. 0.565% Next $1.5 billion.................................................. 0.54% Next $2.5 billion.................................................. 0.515% Next $5 billion.................................................... 0.49% Over $10 billion................................................... 0.465% AIM GLOBAL HEALTH CARE FUND NET ASSETS ANNUAL RATE ---------- ----------- First $350 million................................................. 0.75% Next $350 million.................................................. 0.65% Next $1.3 billion.................................................. 0.55% Next $2 billion.................................................... 0.45% Next $2 billion.................................................... 0.40% Next $2 billion.................................................... 0.375% Over $8 billion.................................................... 0.35% AIM TRIMARK ENDEAVOR FUND NET ASSETS ANNUAL RATE ---------- ----------- First $1 billion................................................... 0.80% On amounts thereafter.............................................. 0.75% AIM TRIMARK FUND AIM TRIMARK SMALL COMPANIES FUND NET ASSETS ANNUAL RATE ---------- ----------- First $1 billion................................................... 0.85% On amounts thereafter.............................................. 0.80%"
Sample 1
AutoNDA by SimpleDocs
AIM DEVELOPING MARKETS FUND. NET ASSETS ANNUAL RATE ---------- ----------- First $500 million ..... 0.975% Next $500 million ...... 0.95% Next $500 million ...... 0.925% On amounts thereafter .. 0.90% AIM GLOBAL HEALTH CARE FUND NET ASSETS ANNUAL RATE ---------- ----------- First $350 million .. 0.75% Next $350 million ... 0.65% Next $1.3 billion ... 0.55% Next $2 billion ..... 0.45% Next $2 billion ..... 0.40% Next $2 billion ..... 0.375% Over $8 billion ..... 0.35% AIM TRIMARK ENDEAVOR FUND
Sample 1
AIM DEVELOPING MARKETS FUND. NET ASSETS ANNUAL RATE ---------- ----------- First $500 million.............................................................. 0.975% Next $500 million............................................................... 0.95% Next $500 million............................................................... 0.925% On amounts thereafter........................................................... 0.90% AIM GLOBAL HEALTH CARE FUND NET ASSETS ANNUAL RATE ---------- ----------- First $350 million.............................................................. 0.75% Next $350 million............................................................... 0.65% Next $1.3 billion............................................................... 0.55% Next $2 billion................................................................. 0.45% Next $2 billion................................................................. 0.40% Next $2 billion................................................................. 0.375% Over $8 billion................................................................. 0.35% AIM TRIMARK ENDEAVOR FUND NET ASSETS ANNUAL RATE ---------- ----------- First $1 billion................................................................ 0.80% On amounts thereafter........................................................... 0.75% AIM TRIMARK FUND AIM TRIMARK SMALL COMPANIES FUND NET ASSETS ANNUAL RATE ---------- ----------- First $1 billion................................................................ 0.85% On amounts thereafter........................................................... 0.80%"
Sample 1
AIM DEVELOPING MARKETS FUND. NET ASSETS ANNUAL RATE ---------- ----------- First $500 million...... 0.975% Next $500 million....... 0.95% Next $500 million....... 0.925% On amounts thereafter... 0.90% AIM INTERNATIONAL TOTAL RETURN FUND
Sample 1
AIM DEVELOPING MARKETS FUND. NET ASSETS ANNUAL RATE ---------- ----------- First $500 million ..... 0.975% Next $500 million ...... 0.95% Next $500 million ...... 0.925% On amounts thereafter .. 0.90% AIM ENHANCED SHORT BOND FUND NET ASSETS ANNUAL RATE ---------- ----------- First $1 billion .. 0.45% Next $4 billion ... 0.425% Over $5 billion ... 0.40% AIM INTERNATIONAL BOND FUND NET ASSETS ANNUAL RATE ---------- ----------- First $250 million .. 0.65% Next $250 million ... 0.59% Next $500 million ... 0.565% Next $1.5 billion ... 0.54% Next $2.5 billion ... 0.515% Next $5 billion ..... 0.49% Over $10 billion .... 0.465% AIM GLOBAL HEALTH CARE FUND NET ASSETS ANNUAL RATE ---------- ----------- First $350 million .. 0.75% Next $350 million ... 0.65% Next $1.3 billion ... 0.55% Next $2 billion ..... 0.45% Next $2 billion ..... 0.40% Next $2 billion ..... 0.375% Over $8 billion ..... 0.35% AIM TRIMARK ENDEAVOR FUND
Sample 1

Related to AIM DEVELOPING MARKETS FUND

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Joint Marketing The Parties shall engage in joint marketing activities pursuant to Section 7.7 of this Agreement and any other joint marketing agreement that may be entered into from time to time.

  • Business Development Company Status The Company, during a period of at least 12 months from the Closing Time, will use its commercially reasonable efforts to maintain its status as a business development company; provided, however, the Company may cease to be, or withdraw its election as, a business development company, with the approval of the board of directors and a vote of stockholders as required by Section 58 of the 1940 Act or any successor provision.

  • Clinical Development (a) Stellartech shall design, develop and construct a Clinical Unit for each of the Thermage Disposable Device and the Thermage Generator, and any required component or subassembly thereof and shall deliver such Clinical Units to Thermage in accordance with the Development Program; (b) Stellartech shall deliver to Thermage such other Deliverables as are contemplated by the Development Program in accordance with the Development Program; and (c) as requested by Thermage and automatically at the conclusion of the Development Program, Stellartech, so long as Thermage is not in breach of its material obligation hereunder, shall deliver in writing to Thermage any and all data and information held by or in the control of Stellartech which is necessary or useful to obtain regulatory approval of the Products in the United States or any foreign country.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Business Development Provide advice and assistance in business growth and development of Party B. 业务发展。对乙方的业务发展提供建议和协助。

  • Statistical and Marketing-Related Data All statistical or market-related data included or incorporated by reference in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, or included in the Marketing Materials, are based on or derived from sources that the Company reasonably believes to be reliable and accurate, and the Company has obtained the written consent to the use of such data from such sources, to the extent required.

  • Secondary Market Trading and Standard & Poor’s If the Company does not maintain the listing of the Public Securities on Nasdaq or another national securities exchange, the Company will (i) apply to be included in Standard & Poor’s Daily News and Corporation Records Corporate Descriptions for a period of five years from the consummation of a Business Combination, (ii) take such commercially reasonable steps as may be necessary to obtain a secondary market trading exemption for the Company’s securities in the State of California and (iii) take such other action as may be reasonably requested by the Representative to obtain a secondary market trading exemption in such other states as may be requested by the Representative; provided that no qualification shall be required in any jurisdiction where, as a result thereof, the Company would be subject to service of general process or to taxation as a foreign corporation doing business in such jurisdiction.

  • Promotion and Marketing For the purpose of promotion and marketing, the Borrower hereby authorizes and consents to the reproduction, disclosure and use by the Lenders and the Agent of its name, identifying logo and the Facilities. The Borrower acknowledges and agrees that the Lenders shall be entitled to determine, in their sole discretion, whether to use such information; that no compensation will be payable by the Lenders or the Agent in connection therewith; and that the Lenders and the Agent shall have no liability whatsoever to it or any of its employees, officers, directors, affiliates or shareholders in obtaining and using such information as contemplated herein.

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

Time is Money Join Law Insider Premium to draft better contracts faster.